Qiao Wu Selected Research

MicroRNAs (MicroRNA)

1/2023	Exosomal MicroRNA Profiling in Vitreous Humor Derived From Pathological Myopia Patients.
1/2017	miR-15a-3p and miR-16-1-3p Negatively Regulate Twist1 to Repress Gastric Cancer Cell Invasion and Metastasis.
4/2016	Challenges in detecting pre-malignant pancreatic lesions during acute pancreatitis using a serum microRNA assay: a study based on KrasG12D transgenic mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qiao Wu Research Topics

Disease

35	Neoplasms (Cancer) 12/2023 - 09/2002
10	Stomach Neoplasms (Stomach Cancer) 01/2017 - 06/2002
7	Carcinogenesis 10/2021 - 02/2012
6	Neoplasm Metastasis (Metastasis) 01/2021 - 09/2002
6	Breast Neoplasms (Breast Cancer) 11/2020 - 01/2004
5	Inflammation (Inflammations) 12/2023 - 07/2021
4	Pancreatic Neoplasms (Pancreatic Cancer) 08/2022 - 10/2014
4	Melanoma (Melanoma, Malignant) 12/2018 - 02/2014
4	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 08/2011
3	Brain Injuries (Brain Injury) 02/2024 - 07/2021
3	Atherosclerosis 12/2023 - 01/2013
3	Colorectal Neoplasms (Colorectal Cancer) 08/2023 - 05/2012
3	Hypertension (High Blood Pressure) 01/2023 - 06/2012
3	Cholelithiasis 07/2014 - 01/2012
2	Cerebral Hemorrhage 02/2024 - 11/2021
2	Wounds and Injuries (Trauma) 02/2024 - 09/2022
2	Atherosclerotic Plaque (Atheroma) 12/2023 - 01/2022
2	Mitochondrial Diseases (Mitochondrial Disease) 08/2023 - 01/2022
2	Hyperuricemia 06/2023 - 01/2023
2	Demyelinating Diseases (Demyelinating Disease) 02/2023 - 07/2021
2	Neuroinflammatory Diseases 02/2023 - 11/2021
2	Insulin Resistance 01/2023 - 11/2012
2	Cholangitis 08/2022 - 03/2022
2	Hypoxia (Hypoxemia) 07/2021 - 05/2021
2	Reperfusion Injury 05/2021 - 08/2011
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 02/2015
2	Cholangiocarcinoma 01/2020 - 01/2012
2	Hyperplasia 01/2020 - 01/2012
2	Lymphatic Metastasis 01/2020 - 01/2012
2	Carcinoma (Carcinomatosis) 01/2020 - 11/2003
2	Liver Diseases (Liver Disease) 08/2018 - 08/2011
2	Obstructive Jaundice (Cholestatic Jaundice) 06/2015 - 12/2012
2	Obesity 06/2015 - 06/2012
2	Colonic Neoplasms (Colon Cancer) 10/2014 - 02/2012
2	Chronic Pancreatitis 07/2014 - 01/2012
2	Cholecystolithiasis 07/2014 - 01/2012
2	Hypersplenism (Anemia, Splenic) 04/2005 - 08/2004
2	Portal Hypertension 04/2005 - 08/2004
2	Nasopharyngeal Carcinoma 02/2005 - 10/2004
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023
1	Enteritis 12/2023
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2023
1	Weight Loss (Weight Reduction) 07/2023

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2002
7	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 11/2020 - 08/2011
5	Biomarkers (Surrogate Marker)IBA 01/2023 - 04/2016
4	CholesterolIBA 01/2023 - 01/2012
4	Messenger RNA (mRNA)IBA 01/2017 - 11/2003
4	Blood Glucose (Blood Sugar)IBA 11/2012 - 01/2012
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 11/2004 - 06/2002
3	Cytochromes c (Cytochrome c)IBA 08/2023 - 12/2004
3	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2023 - 07/2011
3	CytokinesIBA 01/2023 - 05/2015
3	MicroRNAs (MicroRNA)IBA 01/2023 - 04/2016
3	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 01/2017
3	cytosporone BIBA 11/2020 - 09/2008
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 11/2004
3	Antineoplastic Agents (Antineoplastics)IBA 10/2014 - 12/2006
3	Member 1 Group A Nuclear Receptor Subfamily 4IBA 02/2014 - 08/2011
2	IronIBA 02/2024 - 12/2018
2	Epoxide HydrolasesIBA 02/2024 - 11/2021
2	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 02/2012
2	Oxygen (Dioxygen)IBA 07/2023 - 07/2021
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2023 - 01/2023
2	Triglycerides (Triacylglycerol)IBA 01/2023 - 02/2012
2	HDL LipoproteinsIBA 01/2023 - 07/2014
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2023 - 07/2014
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2022 - 01/2012
2	EnzymesIBA 10/2021 - 12/2017
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2007
2	Fatty Acids (Saturated Fatty Acids)IBA 11/2020 - 01/2018
2	Orphan Nuclear ReceptorsIBA 01/2020 - 05/2015
2	Phosphotransferases (Kinase)IBA 01/2019 - 02/2012
2	Membrane Proteins (Integral Membrane Proteins)IBA 12/2018 - 10/2004
2	Estrogen ReceptorsIBA 10/2018 - 05/2017
2	Mitochondrial DNA (mtDNA)IBA 06/2015 - 12/2012
2	Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA 05/2015 - 01/2015
2	LigandsIBA 10/2014 - 08/2011
2	Apoprotein(a) (Apolipoprotein (a))IBA 07/2014 - 01/2012
2	oxidized low density lipoproteinIBA 01/2013 - 01/2012
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 06/2012 - 01/2012
2	Indicators and Reagents (Reagents)IBA 09/2008 - 11/2003
2	Proteasome Endopeptidase Complex (Proteasome)IBA 06/2004 - 09/2003
2	Retinoid X Receptor alphaIBA 06/2004 - 09/2003
2	Retinoic Acid Receptor alphaIBA 06/2004 - 09/2002
2	Etoposide (VP 16)FDA LinkGeneric 11/2003 - 06/2002
2	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2002 - 06/2002
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2023
1	Atorvastatin (Lipitor)FDA Link 12/2023
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2023
1	Milk Proteins (Milk Protein)IBA 12/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2023
1	Mannose (D-Mannose)IBA 12/2023
1	Polo-Like Kinase 1IBA 08/2023

Therapy/Procedure

16	Therapeutics 01/2023 - 02/2012
3	Radiofrequency Ablation 01/2021 - 08/2004
2	Liver Transplantation 03/2021 - 08/2011
2	Lasers (Laser) 10/2020 - 12/2019
1	Drug Therapy (Chemotherapy) 12/2023
1	Secondary Prevention 06/2023